Total Payments
$6,039
2024 Payments
$326.81
Companies
36
Transactions
491
Medicare Patients
1,727
Medicare Billing
$138,700
Payment Breakdown by Category
Food & Beverage$6,028 (99.8%)
Education$11.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,028 | 489 | 99.8% |
| Education | $11.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $686.34 | 87 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $639.56 | 48 | $0 (2023) |
| Lilly USA, LLC | $592.64 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $591.38 | 47 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $539.74 | 31 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $322.10 | 33 | $0 (2021) |
| Novo Nordisk Inc | $306.21 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $302.38 | 42 | $0 (2021) |
| ABBVIE INC. | $286.84 | 23 | $0 (2024) |
| Amgen Inc. | $284.53 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.81 | 18 | Amgen Inc. ($87.31) |
| 2023 | $410.38 | 22 | Lilly USA, LLC ($87.15) |
| 2022 | $176.45 | 12 | Esperion Therapeutics, Inc. ($48.82) |
| 2021 | $1,272 | 90 | AbbVie Inc. ($228.07) |
| 2020 | $502.02 | 36 | GlaxoSmithKline, LLC. ($139.79) |
| 2019 | $912.61 | 72 | PFIZER INC. ($204.04) |
| 2018 | $1,101 | 107 | Boehringer Ingelheim Pharmaceuticals, Inc. ($175.08) |
| 2017 | $1,338 | 134 | AstraZeneca Pharmaceuticals LP ($166.54) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Endocrinology | ||||||
| 05/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 04/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: UROLOGY | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $81.90 | General |
| 11/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 477 | 669 | $71,155 | $42,128 |
| 2022 | 6 | 400 | 555 | $60,821 | $36,771 |
| 2021 | 9 | 405 | 485 | $73,197 | $32,302 |
| 2020 | 8 | 445 | 528 | $70,868 | $27,499 |
Total Patients
1,727
Total Services
2,237
Medicare Billing
$138,700
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 274 | $41,100 | $20,678 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $11,900 | $9,869 | 82.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 92 | $9,200 | $4,947 | 53.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 21 | 26 | $3,900 | $3,634 | 93.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 91 | 91 | $2,275 | $1,470 | 64.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 84 | 84 | $2,100 | $1,356 | 64.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $680.00 | $174.25 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 245 | $39,243 | $21,090 | 53.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $9,653 | $8,131 | 84.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 76 | $7,600 | $4,922 | 64.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 79 | 79 | $1,975 | $1,305 | 66.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 74 | 74 | $1,850 | $1,201 | 64.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $500.00 | $122.32 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 102 | 102 | $22,338 | $12,927 | 57.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 160 | $32,320 | $11,766 | 36.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 99 | $13,687 | $5,493 | 40.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 19 | $2,128 | $1,240 | 58.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 25 | 34 | $1,054 | $330.14 | 31.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 21 | $798.00 | $328.02 | 41.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $444.00 | $112.10 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 25 | 27 | $351.00 | $81.00 | 23.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 11 | 11 | $77.00 | $24.75 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 117 | 117 | $25,623 | $12,951 | 50.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 126 | $25,452 | $7,356 | 28.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 87 | $11,919 | $3,983 | 33.4% |
About Beth Holmes D O Faafp
Beth Holmes D O Faafp is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376544221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Holmes D O Faafp has received a total of $6,039 in payments from pharmaceutical and medical device companies, with $326.81 received in 2024. These payments were reported across 491 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,028).
As a Medicare-enrolled provider, Holmes D O Faafp has provided services to 1,727 Medicare beneficiaries, totaling 2,237 services with total Medicare billing of $138,700. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 08/02/2005
- Last Updated 07/31/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376544221
Products in Payments
- FARXIGA (Drug) $387.88
- TRULICITY (Drug) $321.87
- TRELEGY ELLIPTA (Drug) $276.90
- CHANTIX (Drug) $255.48
- NURTEC ODT (Drug) $216.36
- XARELTO (Drug) $194.02
- JARDIANCE (Drug) $176.76
- TRADJENTA (Drug) $176.26
- MOUNJARO (Drug) $155.60
- VRAYLAR (Drug) $145.95
- UBRELVY (Drug) $141.14
- XIFAXAN (Drug) $129.66
- JANUVIA (Drug) $119.77
- SHINGRIX (Biological) $115.55
- STIOLTO RESPIMAT (Drug) $114.83
- LYRICA (Drug) $114.46
- INVOKANA (Drug) $108.36
- MYRBETRIQ (Drug) $94.16
- Otezla (Drug) $87.31
- Prolia (Biological) $85.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475